Inventor
OH SEI RYANG
KR37 patents
⚠️ This page may combine multiple inventors who share the name “OH SEI RYANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY
9 patentsUS12390505B2Aug 19, 2025
Composition for preventing or treating obesity or diabetes, comprising acanthopanax senticosus extract and garcinia cambogia extract or compound isolated therefrom
KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY0 citations57
US10376553B2Aug 13, 2019
Pharmaceutical composition for preventing and treating chronic obstructive lung disease containing, as active ingredient, Magnoliae flos extract, fraction, or active fraction thereof
KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY0 citations50
US10053443B2Aug 21, 2018
2-phenylbenzofuran derivatives, method for preparing the same and use of the same for treating inflammatory disease
KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY0 citations50
US10751378B2Aug 25, 2020
Pharmaceutical composition comprising Pistacia weinmannifolia extract, fraction of same or compound separated from same for preventing or treating chronic obstructive pulmonary disease (COPD)
KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY0 citations49
US10413579B2Sep 17, 2019
Pharmaceutical composition for preventing or treating asthma comprising Pistacia weinmannifolia J. Poiss. ex Franch extract or fraction thereof
KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY0 citations48
US9481630B2Nov 1, 2016
Ingenane-type diterpene compound, and pharmaceutical composition for treating or preventing viral infectious diseases containing same
KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY0 citations48
US9820963B2Nov 21, 2017
Composition containing lignan compound as active ingredient for preventing or treating cancer
KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY0 citations45
US9610310B2Apr 4, 2017
Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient
KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY0 citations45
US10092587B2Oct 9, 2018
Antiviral composition containing material involved in phosphatidylcholine synthesis pathway
KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY0 citations39
ENZYCHEM LIFESCIENCES CORP
7 patentsUS10058527B2Aug 28, 2018
Composition containing monoacetyldiacylglycerol compound as active ingredient for inhibiting blood cancer or metastasis
ENZYCHEM LIFESCIENCES CORP4 citations71
US9895337B2Feb 20, 2018
Compositions containing monoacetyldiacylglycerol compound as an active ingredient for preventing or treating rheumatoid arthritis
ENZYCHEM LIFESCIENCES CORP3 citations71
US10098864B2Oct 16, 2018
Composition containing monoacetyldiacylglycerol compound as active ingredient for preventing or treating asthma
ENZYCHEM LIFESCIENCES CORP2 citations70
US9763908B2Sep 19, 2017
Composition containing monoacetyldiglyceride compound as active ingredient for preventing or treating atopic dermatitis
ENZYCHEM LIFESCIENCES CORP4 citations68
US10857119B2Dec 8, 2020
Composition containing monoacetyldiacylglycerol compound as active ingredient for inhibiting blood cancer or metastasis
ENZYCHEM LIFESCIENCES CORP1 citations60
US11135193B2Oct 5, 2021
Composition containing monoacetyldiacylglycerol compound as active ingredient for preventing or treating asthma
ENZYCHEM LIFESCIENCES CORP0 citations59
US10765655B2Sep 8, 2020
Composition containing monoacetyldiglyceride compound as active ingredient for preventing or treating chronic obstructive pulmonary disease
ENZYCHEM LIFESCIENCES CORP1 citations58
YUNGJIN PHARMACEUTICAL CO LTD
6 patentsUS10046019B2Aug 14, 2018
Purified extract (ATC1) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma
YUNGJIN PHARMACEUTICAL CO LTD0 citations48
US9999646B2Jun 19, 2018
Method of treating inflammation, allergy and asthma with a purified extract (ATC1) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient
YUNGJIN PHARMACEUTICAL CO LTD0 citations48
US9675658B2Jun 13, 2017
Method of treating inflammation, allergy and asthma with a purified extract (ATC2) isolated from Pseudolysimachion rotundam var. subintegrum containing abundant amount of active ingredient
YUNGJIN PHARMACEUTICAL CO LTD0 citations48
US9592263B2Mar 14, 2017
Purified extract (ATC2) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma
YUNGJIN PHARMACEUTICAL CO LTD0 citations48
US10172816B2Jan 8, 2019
Method of treating chronic obstructive pulmonary disease (CPD) with verproside
YUNGJIN PHARMACEUTICAL CO LTD0 citations47
US9655871B2May 23, 2017
Composition comprising a purified extract isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient or the compounds isolated therefrom, as an active ingredient for treating a chronic obstructive pulmonary disease and the use thereof
YUNGJIN PHARMACEUTICAL CO LTD0 citations47
KOREA RES INST OF BIOSCIENCE
4 patentsUS7763286B2Jul 27, 2010
Composition comprising an extract of Tiarella polyphylla and tiarellic acid isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
KOREA RES INST OF BIOSCIENCE0 citations48
US9174925B2Nov 3, 2015
Phorbol type diterpene compound, pharmaceutical composition for treatment or prevention of viral infectious diseases including same
KOREA RES INST OF BIOSCIENCE0 citations47
US9061022B2Jun 23, 2015
Pharmaceutical composition for treating wounds or revitalizing skin comprising Euphorbia kansui extracts, fractions thereof or diterpene compounds separated from the fractions as active ingredient
KOREA RES INST OF BIOSCIENCE0 citations45
US7534456B2May 19, 2009
Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatory activity and anti-atherogenic activity
KOREA RES INST OF BIOSCIENCE0 citations45
LEE HYEONG KYU
4 patentsUS8974837B2Mar 10, 2015
Pharmaceutical composition comprising an extract of Pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
LEE HYEONG KYU0 citations47
US8455541B2Jun 4, 2013
Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
LEE HYEONG KYU0 citations47
US8168235B2May 1, 2012
Pharmaceutical composition comprising an extract of Pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
LEE HYEONG KYU0 citations47
US9078912B2Jul 14, 2015
Asthma diagnosis using the neuropilin-1 gene, and method for screening for a therapeutic agent for asthma
LEE HYEONG KYU0 citations42
AHN KYUNG SEOP
2 patentsUS8980846B2Mar 17, 2015
Composition containing styraxlignolide A or the aglycone thereof as an active ingredient for preventing or treating asthma
AHN KYUNG SEOP0 citations46
US8722110B2May 13, 2014
Pharmaceutical composition for preventing or treating inflammatory diseases, allergic diseases or asthma, containing Diospyros blancoi A. DC. extract as active ingredient
AHN KYUNG SEOP0 citations38